Subtilisin QK-2: secretory expression in Lactococcus lactis and surface display onto gram-positive enhancer matrix (GEM) particles by Ruifeng Mao et al.
Mao et al. Microb Cell Fact  (2016) 15:80 
DOI 10.1186/s12934-016-0478-7
RESEARCH
Subtilisin QK-2: secretory expression 
in Lactococcus lactis and surface display 
onto gram-positive enhancer matrix (GEM) 
particles
Ruifeng Mao, Kangping Zhou, Zhenwei Han and Yefu Wang*
Abstract 
Background: Purified from the supernatant of Bacillus subtilis QK02 culture broth, Subtilisin QK-2 is a type of effective 
thrombolytic reagent that has great exploitable potential. However, the unbearable flavor that occurs with fermenta-
tion and the complicated methods that are required to obtain pure products limit the application of this enzyme. 
Lactic acid bacteria (LAB)-based delivery vehicles are promising as cheap and safe options for medicinal compounds. 
The secretory expression and surface display using LAB may popularize Subtilisin QK-2 more easily and conveniently 
with minimal adverse effects.
Results: Subtilisin QK-2 was expressed successfully in two forms using lactic acid bacteria. For the secretory expres-
sion in Lactococcus lactis, Subtilisin QK-2 was efficiently secreted into the culture using the promoter PnisA and signal 
peptide SPUsp. The expression levels were not different in L. lactis NZ9000 and NZ3900 without the effect of differ-
ent selection markers. However, leaky expression was only detected in L. lactis NZ3900. The biological activity of this 
secreted Subtilisin QK-2 was enhanced by modulating the pH of medium to slightly alkaline during induction and 
by codon optimization of either the entire gene sequence (qk′) or only the propeptide gene sequence (qkpro′). For 
surface display onto gram-positive enhancer matrix (GEM) particles, n LysM repeats from the C-terminal region of the 
major autolysin AcmA of L. lactis were fused to either the C-terminus (n = 1, 3, 5) or the N-terminus (n = 1) of the Sub-
tilisin QK-2. These fusion proteins were secreted into the culture medium, and the QK-3LysM was able to bind to the 
surface of various LAB GEM particles without a loss of fibrinolytic activity. Furthermore, the binding capacity signifi-
cantly increased with a higher concentration of QK-3LysM. Compared to the free-form Subtilisin QK-2, the QK-3LysM 
displayed on the surface of GEM particles was more stable in the simulated gastric juice.
Conclusions: Combined with the safety and popularity of LAB, Subtilisin QK-2 may be easily applied worldwide to 
prevent and control thrombosis diseases.
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Background
Microbial fibrinolytic enzymes have recently attracted 
greater attention for thrombolytic therapy. As a homolog 
to Nattokinase (EC 3.4.21.62), Subtilisin QK-2 was 
purified from the supernatant of Bacillus subtilis QK02 
culture broth. Mature Subtilisin QK-2 consists of 275 
amino acid residues (MW =  27.8  kDa) and shows high 
efficiency for directly cross-linked fibrin degradation, as 
determined by SDS-PAGE and the fibrin plate method 
in  vitro [1]. Subtilisin QK-2 inhibits tyrosine nitration 
induced by nitrite, hydrogen peroxide and hemoglobin 
in  vitro and in  vivo and protects human umbilical vein 
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endothelial cells (ECV-304) from damage caused by 
nitrite and hydrogen peroxide [2]. Additionally, Subtilisin 
QK-2 significantly inhibits thrombus formation and dis-
plays strong thrombolytic activity in mice, and its effect 
is better than that of the clinically used lumbrokinase [3]. 
Therefore, Subtilisin QK-2 is a type of effective thrombo-
lytic reagent with great exploitable potential, similar to 
Nattokinse.
Lactic acid bacteria (LAB), which are widely used in 
the food industry, are present in the intestines of most 
animals, including humans. Because many have been 
granted “generally regarded as safe” (GRAS) status, 
these bacteria can be used as live vehicles for antigenic, 
functional proteins or for DNA delivery to the mucosal 
surface [4]. As the best-studied LAB over the last two 
decades, Lactococcus lactis is an ideal bacteria for the 
food-grade production of recombinant proteins, and 
many expression systems have been developed and used 
in the production of heterologous proteins in L. lactis 
[5]. One of the most powerful expression systems used 
in LAB is the nisin controlled expression (NICE) sys-
tem, which is based on the genes involved in the biosyn-
thesis and regulation of the antimicrobial peptide, nisin 
[4]. Using the NICE system, heterologous proteins can 
be targeted to a specific cell location, including the cyto-
plasm, cell surface or extracellular medium. By evaluat-
ing the influence of localization on the production yields 
in L. lactis, it was concluded that secretion is preferable 
to cytoplasmic production [6]. The absence of an outer 
membrane in LAB makes them particularly attractive 
for exposing bioactive molecules to the extracellular 
compartment. Anchoring proteins or peptides onto the 
surface of LAB is promising in various fields of biotech-
nological applications [7]. Depending on whether it is 
genetically modified, surface-engineered LAB can be 
divided into two types, a genetically modified organism 
(GMO) and a non-living and non-genetically modified 
gram-positive bacterial delivery particle, which is also 
referred to as gram-positive enhancer matrix (GEM). For 
the GMO type, the expression and display of the passen-
ger protein occurs in the same cell that contains the pas-
senger and anchor fusion gene in the expression plasmid 
or the genome. By contrast, the expression and display of 
the fusion protein for the GEM type are separated, such 
that this type needs two different cells, one cell expresses 
the fusion protein, and the pretreated LAB cell is com-
bined with the fusion protein to bind the anchor to the 
surface of the GEM particle using the anchor domain 
contained in the fusion protein [8]. The expression strain 
can be yeast or Escherichia coli in addition to LAB. The 
LysM repeat exists in the C-terminal region of the major 
autolysin AcmA (GenBank: U17696.1) of L. lactis and is 
the anchor domain that is most frequently used to display 
proteins or peptides on GEM particles [8–12]. Fused with 
the LysM anchor domain to its C-terminus, α-amylase of 
Bacillus licheniformis is secreted into the culture medium 
by L. lactis NZ9000 and can bind to the surface of trichlo-
roacetic acid (TCA)-pretreated LAB GEM particles with-
out a loss of its functional activity [10]. To promote the 
application of Subtilisin QK-2, we report the secreted 
expression of this enzyme in L. lactis and surface display 
onto various LAB GEM particles.
Results
Construction of QK‑secreting and QK‑displaying plasmids
All plasmids constructed in this study are shown in Fig. 1. 
All plasmids contain the Usp45 signal peptide sequence 
(spUsp), which enables protein secretion, and is driven 
by the inducible promoter PnisA. For secretion of the 
free Subtilisin QK-2, the wild qk, the codon-optimized 
qk′ and the only optimized propeptide sequence qkpro′ 
(a gene sequence alignment diagram can be found in 
Additional file  1: Figure S1), were included as shown 
in Fig. 1b. The LysM repeats from the acmA of L. lactis 
MG1363 were fused with the qk gene to display this ser-
ine protease onto the surface of LAB GEM particles. As 
shown in Fig. 1d, the nLysM repeats were fused either to 
the C-terminus (n = 1, 3, 5) or the N-terminus (n = 1) of 
Subtilisin QK-2.
Secretory expression of free Subtilisin QK‑2
Under the optimized induction conditions (Additional 
file 1: Figure S2), nisin (70 ng/ml) was added for induc-
tion when the OD600 of the culture reached approxi-
mately 0.5. Then, the culture was incubated at 30  °C for 
8 h. A specific band of 28 kDa (identical to the molecular 
mass of mature Subtilisin QK-2) was detected by west-
ern blotting analysis of the supernatant of the induced 
culture (Fig.  2a) but not in the intracellular lysate (data 
not shown). The resulting fibrinolytic activity reached 
approximately 52.3 urokinase units per milliliter culture 
(Figs.  2b, 3). By testing the fibrinolytic activity of the 
supernatant culture and the intracellular lysate, secretion 
efficiency was evaluated, and approximately 96 % of the 
Subtilisin QK-2 was secreted into the medium. Interest-
ingly, the specific protein bands in the western blot and 
clearing zones in the fibrinolytic activity analysis were 
detected not only in the supernatant of the induced 
culture but also in the non-induced culture of L. lactis 
NZ3900 (pRF02/pRF02H/pRF03H) (Figs. 2, 3). However, 
Subtilisin QK-2 was detected only in the induced L. lactis 
NZ9000. Under the optimized induction conditions, the 
expression levels in NZ9000 and NZ3900 were approxi-
mately the same, regardless of the selection method used 
(Fig.  3). By comparing the fibrinolytic activity of the 
protein samples with the His-tag or untagged proteins 
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(Fig. 3), it was concluded that the His-tag did not inter-
fere with the production or activity of this expressed 
protein.
Effect of pH modulation on Subtilisin QK‑2 expression
Subtilisin QK-2 is an alkaline protease, and the pH of the 
medium may play an important role in the expression of 
this protease. To regulate the pH of the medium, NaOH 
was added once at 1, 2, or 3 h after induction. The early 
addition of NaOH (at 1 or 2 h) has an inhibitory effect on 
growth, as determined by the OD600 readings (data not 
shown). By adding NaOH at 3 h after induction, the end-
ing pH of the medium was 7.3–7.9, and a higher fibrino-
lytic activity (p < 0.05) was detected as shown in Fig. 3.
Codon usage analysis and effect of codon optimization
The results of the codon usage analysis showed that there 
are only 23 “low” (10–20 %) usage frequency codons and no 
“very low” (<10 %) usage frequency codons in the codons of 
the qk gene, as defined in Methods; and that the percentage 
of “unfavorable” codons is only approximately 6.5 % (23 in 
353). Of these 23 rare codons, 11 codons appear in the first 
106 codons, which encode the propeptide sequence. Both 
the wild-type Subtilisin QK-2 gene (qk) and the codon-
optimized gene (qk′ and qkpro′) were expressed in the 
same way, and the results were used to study the effect of 
codon optimization on heterologous expression in L. lac-
tis. Compared to the wild-type Subtilisin QK-2 expressed 
in L. lactis NZ9000 (pRF03H), stronger fibrinolytic activ-
ity (p < 0.05) was detected in the induced culture of L. lac-
tis NZ9000 (pRF04H) and NZ9000 (pRF05H) (Fig. 3). The 
fibrinolytic activity detected in L. lactis NZ9000 (pRF04H) 
and NZ9000 (pRF05H) was similar (Fig.  3). Although the 
bioactivity of the expressed Subtilisin QK-2 was improved 
by pH modulation or codon optimization, no visible spe-
cific protein band was observed by SDS-PAGE analysis, and 
the protein bands detected in the western blotting analysis, 
even for the 50-fold concentrated samples, were compara-
ble to these with no pH modulation or codon optimization 
(data not shown).
Expression and characterization of fusion proteins
To use the anchor ability of the LysM repeat, four different 
plasmids were constructed and transformed into L. lac-
tis NZ9000. After induction with no pH modulation, the 
supernatant was used for western blotting analysis and the 
results are shown in Fig. 4. All C-terminus fusion samples 
(QK-1LysM, QK-3LysM, QK-5LysM) showed immunoreac-
tive protein bands of 35, 51 and 66 kDa, respectively, which 
were the expected size of the recombinant proteins. How-
ever, degradation was observed in the protein samples from 
L. lactis NZ9000 (pRF08H), which contained five LysM 
repeats (QK-5LysM). For the N-terminus fusion protein 
sample (1LysM-QK), a 44 kDa protein band was detected, 
which was larger than the expected size of 35 kDa. Analysis 
of the fibrinolytic activity of these fusion proteins showed 
Fig. 1 Schematic illustration of proteins or vectors. a Schematic illustration of the Subtilisin QK-2 protein. SP signal peptide; P propeptide; M mature 
peptide. b Schematic illustration of secretory expression vectors. PnisA promoter; SPusp secretion signal sequence for L. lactis; qk (b-1) wild-type 
gene; qk′ (b-2) the entire gene sequence with codon optimization; qkpro’ (b-3) the only codon-optimized propeptide gene sequence. (b-1) contains 
plasmids pRF02, pRF02H, pRF03 and pRF03H. (b-2) indicates plasmid pRF04H. (b-3) indicates plasmid pRF05H. c Schematic illustration of the AcmA 
protein. S.S. signal sequence; A.D. active domain; LysM anchoring repeats; d schematic illustration of vectors for surface display. (d-1), (d-2), (d-3) and 
(d-4) indicate plasmids pRF06H, pRF07H, pRF08H and pRF09H, respectively. pRF02 and pRF02H were selected by the complementation of the lacF 
gene and others were selected by the chloramphenicol resistant gene. H his-tag
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that only the C-terminus fusion samples maintained 
their enzymatic activity; of these three fusion proteins, 
the enzymatic activity of QK-1LysM and QK-3LysM was 
approximately 85.7 and 82.4 %, respectively of the free form 
Subtilisin QK-2 expressed in L. lactis NZ9000 (pRF03H), 
and the activity of QK-5LysM was significantly decreased 
(Table 1). Therefore, the binding assay was performed with 
the QK-1LysM and QK-3LysM fusion proteins.
Binding of QK‑1LysM and QK‑3LysM to LAB GEM particles
After incubation with 5  ml cell-free culture medium 
containing QK-1LysM or QK-3LysM, loaded GEM par-
ticles were washed and used for western blotting analy-
sis and measure of fibrinolytic activity, as described in 
the “Methods” section. The GEM samples that were not 
incubated with the fusion protein or for those incubated 
Fig. 2 Western blotting analysis (a) and fibrinolytic activity analysis 
(b) of Subtilisin QK-2 expressed in L. lactis. 1 five times concentrated 
supernatant of noninduced L. lactis NZ3900 (pRF02H); 2 supernatant 
of induced L. lactis NZ3900 (pRF02H); 3 five times concentrated 
supernatant of noninduced L. lactis NZ3900 (pRF03H); 4 supernatant 
of induced L. lactis NZ3900 (pRF03H); 5 five times concentrated 
supernatant of noninduced L. lactis NZ9000 (pRF03H); 6 supernatant 
of induced L. lactis NZ9000 (pRF03H); 7 supernatant culture of the 
Bacillus subtilis QK02. The protein amounts analyzed in western blot 
were three times that of the fibrinolytic activity analysis
Fig. 3 Fibrinolytic activity analysis of different recombinant L. lactis 
strains under the indicated induction conditions. pH modulation 
indicates that addition of NaOH into the medium at 3 h after induc-
tion; (−) meaning without pH modulation, (+) meaning with pH 
modulation. All data presented were mean ± SD of three replicate 
experiments (*p < 0.05)
Fig. 4 Western blotting analysis of the fusion proteins from the 
induced supernatant. 1 cells harboring pRF06H expressing QK-1LysM; 
2 cells harboring pRF07H expressing QK-3LysM; 3 cells harboring 
pRF08H expressing QK-5LysM; 4 cells harboring pRF09H expressing 
1LysM-QK; 5 cells harboring pNZ8048, negative control. The right 
arrows indicated the expected size, respectively
Table 1 Fibrinolytic activity of different form QK
Protein Activity (U/ml) Percentage (%)
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with the free Subtilisin QK-2 exhibited no protein bands 
(data not shown). Both fusion proteins bound to the 
GEM particles; however, the binding of QK-1LysM was 
poor because a considerable amount of this fusion pro-
tein remained in the culture medium after binding, as 
shown in Additional file1: Figure S3. By contrast, the pro-
tein amounts of the QK-3LysM bound to various LAB 
GEM particles were higher as determined by western 
blot and analysis of the fibrinolytic activity (Fig. 5). The 
binding efficiency calculated by western blot and analysis 
of the fibrinolytic activity was similar for the correspond-
ing LAB GEM particles. The results show that the bind-
ing capacity of the L. lactis MG1363 particles is about 
100  %, and the relative percentages for the other LAB 
GEM particles are also shown. Approximately  >90  % of 
the activity was retained after this fusion protein bound 
to LAB GEM particles (Fig. 5B). Successful binding was 
also confirmed by immunofluorescence microscopy, as 
shown in Additional file 1: Figure S4. When the LAB par-
ticles were incubated with a high concentration of QK-
3LysM, the binding capacity was significantly increased 
(data not shown).
Stability in simulated gastric juice
Simulated gastric juice (GJ) was used to test the stabil-
ity of the free form Subtilisin QK-2 and the QK-3LysM 
displayed onto the surface of L. lactis MG1363 GEM 
particles. As shown in Fig. 6, the reduced activity of the 
loaded MG1363 GEM particles was less than 18 %, even 
after 30 min at pH 2.0, and the reduction was greater for 
the free form Subtilisin QK-2, which lost 63 % fibrinolytic 
activity compared to the positive control (Fig. 6).
Discussion
Fibrinolytic enzymes derived from microorganisms have 
attracted more interest in thrombolytic therapy than typ-
ical thrombolytic agents, which have drawbacks, includ-
ing the undesirable side effects, low specificity toward 
fibrin, and high cost [13]. Subtilisin QK-2 is a subtili-
sin-family serine protease, and previous studies have 
revealed that it is a type of effective thrombolytic reagent 
with highly exploitable potential [1–3]. In this study, Sub-
tilisin QK-2 was first successfully expressed in two forms, 
including secretory expression and LAB GEM particles-
surface display, using the NICE system in L. lactis.
Nattokinase is expressed in B. subtilis [14] and E. coli 
[15, 16]; however, complicated purification processes 
must be performed before the expressed enzyme can 
be applied for clinical use. Although the intracellular 
[17] and intercellular [18] expression of Nattokinase 
in L. lactis was studied, the recombinant strains con-
tained antibiotic (chloramphenicol and erythromycin, 
Fig. 5 Analysis of the binding efficiency of QK-3LysM. A Western 
blot analysis of the culture supernatant after binding assay (a) and 
the QK-3LysM loaded LAB GEM particles (b); the relative binding rate 
is shown for each LAB GEM particle. B Fibrinolytic activity analysis of 
QK-3LysM before and after binding assay; all data presented were 
mean ± SD of three replicate experiments. 1 L. lactis MG1363; 2 L. 
casei; 3 L. paracasei; 4 S. thermophilus; 5 L. bulgaricus ATCC 11842; 6 L. 
plantarum ST-III
Fig. 6 Stability analysis of different form of Subtilisin QK-2 in simu-
lated gastric juice. The free form Subtilisin QK-2 (A) and QK-3LysM 
binding to the surface of L. lactis MG1363 GEM particles (B) were 
incubated with simulated gastric juice of pH 4.0 (GJ-pH 4) or pH 2.0 
(GJ-pH 2). The samples incubated with PBS (pH 7.0) were used as 
positive control. All data presented were mean ± SD of three repli-
cate experiments
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respectively) resistance genes and thus, do not adhere to 
the real “food-grade” definition [5]. Without using antibi-
otics, Subtilisin QK-2 was expressed in L. lactis NZ3900 
(pRF02), which was selected by the complementation of 
the lacF gene in this study, which allowed it to meet the 
food-grade requirements.
Leaky expression of the qk gene from the nisA pro-
moter was observed in the recombinant strain L. lactis 
NZ3900. It has been proposed that this leaky expression 
is a property of the NICE system itself [19]. However, the 
reason for this phenomenon is unknown and requires 
further study.
Under the optimized induction conditions, the expres-
sion levels in L. lactis NZ3900 (pRF02H or pRF03H) 
and NZ9000 (pRF03H) were similar, regardless of the 
selection marker used. After 6 and 8 h of induction, the 
cell growth and production of Subtilisin QK-2 began to 
decrease, respectively (Additional file 1: Figure S2). How-
ever, it is not appropriate to compare the production 
levels after a long induction time in L. lactis because the 
plasmid stability may not be a key factor [20] that inter-
feres with the production of Subtilisin QK-2.
As an alkaline protease, the optimal pH of Subtilisin 
QK-2 is approximately 8.5, and it is unstable in acidic 
environment. Because of the production of lactic acid 
during fermentation, the pH of the L. lactis culture 
decreases. During the fermentation of the recombinant L. 
lactis NZ9000 (pRF03H) strain, the pH decreased to 5.4, 
which may affect the expression of Subtilisin QK-2. This 
is confirmed by regulating the pH of the medium with 
NaOH. With a slightly alkaline (pH 7.3–7.9) medium, 
Subtilisin QK-2 had a stronger bioactivity (Fig. 3), which 
may be attributed to better folding as a result of the addi-
tion of NaOH. The same effect of the pH of the medium 
on the bioactivity of SCI-57 was reported previously [21].
A previous report [22] suggested that codon optimi-
zation strategies could be applied to expression systems 
with LAB as producer strains. In this study, a stronger 
fibrinolytic activity was found using codon optimiza-
tion. Furthermore, codon optimization of both the entire 
sequence and the propeptide sequence only has the same 
effect (Fig.  3). However, no positive effect of the codon 
optimization on the yield of this enzyme was detected; 
and this may be attributed to the low expression level of 
QK or the low percentage of rare codons (approximately 
6.5  %). Optimization of these 11 rare codons existed in 
the propeptide sequence may improve the activity of the 
propeptide and then promote the mature polypeptide to 
fold into the proper conformation, which may be more 
active or stable, ultimately leading to the same effect as 
codon optimization of the entire sequence. This also con-
firms the important role of the propeptide played in the 
folding process of the mature peptide [23]. Moreover, this 
finding may offer a new and less expensive method for 
codon optimization with a target protein similar to Sub-
tilisin QK-2.
The display level of traditional surface display systems, 
which are based on the expression of proteins on the pro-
ducer cell surface, is largely dependent on the efficiency 
of expression and translocation, and the host strain is a 
genetically modified organism [24]. However, the use of 
GMOs in applications that involve uncontrolled release 
into the environment, such as foods and vaccines, is less 
desirable or at least under debate [10]. To circumvent 
these problems, gram-positive enhancer matrix (GEM) 
particles can be used as substrates to bind externally 
added heterologous proteins by using a high-affinity 
binding domain. As the most often used binding domain, 
the LysM repeat exists in the C-terminal region of the 
major autolysin AcmA of L. lactis and was used in this 
study to display Subtilisin QK-2 onto various LAB GEM 
particles. For the N-terminus fusion (1LysM-QK), the 
detected protein band was larger than expected (Fig. 4), 
and the excess size was equal to the propeptide which 
should be removed during the translocation process of 
mature Subtilisin QK-2. Therefore, the propeptide was 
not cleaved because of the LysM repeat located between 
the signal peptide and the propeptide. This non-cleaved 
propeptide resulted in the loss of fibrinolytic activity for 
this fusion protein. By contrast, the LysM repeats fused 
to the C-terminus of Subtilisin QK-2 had no influence on 
the cleavage of the propeptide, and the fusion proteins 
were expressed at the expected size (Fig. 4) and retained 
their fibrinolytic activity (Table 1). The fibrinolytic activ-
ity of QK-1LysM and QK-3LysM was comparable (85.7 
and 82.4 %, respectively) to the free Subtilisin QK-2 con-
tained in the induced culture medium, which indicated 
that the added anchor domain (1 or 3 LysM repeats) had 
little impact on the conformation of QK. However, the 
production of the QK-5LysM fusion protein was lower 
and highly degraded (Fig.  4). The degradation may be 
related to the activity of endogenous surface housekeep-
ing proteases, such as HtrA [25], and a greater number of 
LysM repeats could be more easily targeted compared to 
one or three repeats. In addition to degradation, the loss 
of fibrinolytic activity for the QK-5LysM may be attrib-
uted to the stereo-hindrance effect of a larger anchor 
domain. To protect the fusion proteins from degrada-
tion, htrA-deficient strains therefore represent possible 
solutions.
After incubation, QK-1LysM was able to bind to 
GEM particles; however, the binding was poor. With an 
increase in the number of LysM repeats, a clear increase 
in the binding affinity was observed in the binding assay 
of the QK-3LysM fusion protein. This finding is consist-
ent with a previous report [10], in which potent binding 
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to lactococcal GEM particles was obtained using two 
identical AcmA LysM domains. The binding capabilities 
of all LAB GEM particles were comparable (Fig.  5) and 
were higher than those of the natural LAB cells without 
chemical treatment (data not shown). This is because 
the binding of LysM-type repeats to peptidoglycans is 
hindered by other cell wall constituents that exist in the 
natural cell surface [12]. Most importantly, the binding 
capacity increased with a higher concentration of QK-
3LysM fusion proteins, which improved the fibrinolytic 
activity of the same volume loaded onto LAB GEM par-
ticles. Compared to the free Subtilisin QK-2, the QK-
3LysM displayed onto the surface of GEM particles was 
more stable in simulated gastric juice (Fig. 6). This indi-
cated that the loaded GEM particles can protect Sub-
tilisin QK-2 from degradation and retain considerable 
functionality after oral administration. Bound to LAB 
GEM particles, QK-3LysM does not need complex puri-
fication process and can be applied to oral administration 
without any additional adjuvant. Therefore, the lower 
cost of producing subtilisin loaded LAB GEM particles 
would contribute to their widespread application. The 
current administration method of other thrombolytic 
agents (such as Urokinase and Heparin) is injection and 
this route is prone to a number of problems and causes 
huge physical and psychological pressure for patients 
[26], compared to the gastric delivery of the subtilisin 
bound to LAB GEM particles.
The fibrinolytic enzyme Subtilisin QK-2 was success-
fully expressed in the potential probiotic, L. lactis. For the 
secretory expression of Subtilisin QK-2, to avoid potential 
complications with induction in vivo, it may be possible 
to preinduce L. lactis NZ3900 (pRF02) with nisin prior 
to oral administration. Treating L. lactis with a 1-h pulse 
of nisin can induce protein secretion for 10 h [27]. Then 
the recombinant strains can secrete this enzyme in the 
intestinal tract. Furthermore, L. lactis NZ3900 (pRF02) 
can secrete Subtilisin QK-2 without nisin induction, and 
this leaky expression may be considered a type of consti-
tutive expression. To circumvent the use of a genetically 
modified organism and the degradation of free Subtili-
sin QK-2, the QK-LysM fusion protein (without His-tag) 
loaded LAB GEM particles can be used for oral adminis-
tration without additional adjuvants. The highest binding 
capacity for lactococcal GEM particles is approximately 
106 molecules per cell [10]; therefore, a much higher sur-
face density can be obtained by incubation with the cul-
ture medium containing a higher concentration of fusion 
proteins. Additionally other functional proteins can be 
displayed simultaneously onto the same GEM particles 
by incubation with culture medium containing different 
LysM fusion proteins.
Conclusions
Subtilisin QK-2 was successfully expressed using lactic 
acid bacteria in two forms, secretory expression and sur-
face display. For secretory expression, both pH modula-
tion and codon optimization improved the bioactivity 
of this enzyme. In particular, no antibiotic was used in 
the recombinant strain L. lactis NZ3900 (pRF02), which 
attained the “food-grade” standard. For surface display, 
the fusion proteins retain fibrinolytic activity with the 
anchor domain LysM fused to the C-terminus, but not 
the N-terminus, of Subtilisin QK-2, and the QK-3LysM 
fusion protein performs best in binding assay. Compared 
to the free form, Subtilisin QK-2 loaded onto LAB GEM 
particles is more stable in simulated gastric juice. Using 
LAB, Subtilisin QK-2 may become popularized more eas-
ily and conveniently with minimal adverse effects, and it 
is a promising strategy for the prevention and control of 
thrombosis with the potential for widespread application.
Methods
Bacterial strains, plasmids, and culture conditions
The bacterial strains and plasmids used in this study 
are given in Table  2. Strains L. plantarum ST-III [28], 
L. lactis NZ9000 [20], and NZ3900 [20] and plasmids 
pNZ8048 [29] and pNZ8149 [30] were kind gifts from 
Prof. Shanjing Yao, College of Materials Science and 
Chemical Engineering, Zhejiang University. L. del-
brueckii subsp. Bulgaricus ATCC 11842 [31] was a kind 
gift from Xiaoyan Liu, School of Life Science, Huaiyin 
Normal University. E. coli TOP10 (Invitrogen; Carlsbad, 
CA, USA) and B. subtilis QK02 (CCTCC, M203078) 
strains were grown in Luria–Bertani medium with shak-
ing at 37 °C. L. lactis strains were grown statically in M17 
medium (Merck) at 30  °C in tightly capped flasks sup-
plemented with 0.5  % glucose (GM17) or 0.5  % lactose 
(LM17). Lactobacillus strains and S. thermophilus were 
grown in MRS broth (Merck) at 37  °C without aeration. 
Elliker broth [32] was used for the selection of lac+ L. lac-
tis NZ3900 colonies. For plasmid selection in E. coli and 
L. lactis, chloramphenicol (Sigma) was added at 5 μg/ml.
DNA manipulation and transformation
Combined with lysozyme, genomic DNA and/or plas-
mids were extracted from B. subtilis and L. lactis strains 
using a rapid bacterial genomic DNA isolation kit (San-
gon Biotech, Shanghai, China) and a rapid mini plasmid 
kit (Tiangen Biotech, Beijing, China), respectively. To 
study the effect of codon bias on the expression of Subtili-
sin QK-2 in L. lactis, codon optimization was performed 
using the JCat program [33] according to the protein 
sequence of Subtilisin QK-2 (GenBank: AJ579472.2). 
The codon-optimized gene of Subtilisin QK-2 (qk′, Gen-
Bank accession number KT725198) was synthesized by 
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TsingKe Biological Technology (Wuhan, China) and was 
ligated into the pUC19 plasmid, resulting in pUC19-qk′. 
On the basis of the qk′, qkpro′ (GenBank accession num-
ber KT991841) containing the codon-optimized propep-
tide sequence only was obtained by overlap extension 
(SOE)-PCR. KOD Dash DNA polymerase (TOYOBO) 
was used to maintain the veracity of the PCR process. 
Restriction enzymes and T4 DNA ligase were purchased 
from TaKaRa and were used according to the manufac-
turer’s instructions. General molecular biological proce-
dures were performed according to [34].
Construction of expression vectors and recombinant  
L. lacis strains
The primers used in this study for the amplification of tar-
get DNA fragments are listed in Table 3. The spUsp gene, 
amplified from the chromosome of L. lactis MG1363 
using primers P1 and P2, was cloned into NcoI and SphI-
digested pNZ8149 to obtain plasmid pRF01 (Table  2). 
Primers P3 and P4 or P5 were used to amplify the qk gene 
encoding the propeptide and the mature QK-2 from the 
genome of B. subtilis QK02. Then, the resulting genes 
were digested with KpnI and XbaI and finally intro-
duced into pRF01 to obtain plasmids pRF02 and pRF02H 
(Table  2). The spUsp-qk was obtained from pRF02 or 
pRF02H using NcoI and XbaI digestion, and this fusion 
gene was introduced into the same digested pNZ8048 
to obtain plasmids pRF03 or pRF03H (Table 2). Primers 
P6 and P7 were used to amplify the codon-optimized qk′ 
gene from the plasmid pUC19-qk′. The resulting frag-
ment was introduced into pRF03H by KpnI and XbaI 
digestion to obtain plasmid pRF04H (Table  2), which 
contained the codon-optimized qk′ instead of the wild-
type qk gene. The optimized propeptide gene sequence 
(pro′) was amplified from pUC19-qk′ using primers P6 
and P8 containing 15 overlapping nucleotides with the 
5′ end of the mature peptide gene sequence in wild-type 
qk gene. The mature peptide gene sequence (M) was 
amplified from plasmid pRF03H using primers P9 and 
P10. Using primers P6 and P10, the codon-optimized 
Table 2 Bacterial strains and plasmids
Strain or plasmid Relevant properties Reference or source
Strains
 E. coli TOP10 Cloning host Invitrogen
 B. subtilis QK02 QK producing bacterium, wild strain CCTCC
 L. lactis MG1363 Subsp. cremoris, plasmid-free Our lab
 L. lactis NZ9000 Derivative of MG1363 with integration
nisRK into chromosome
[19]
 L. lactis NZ3900 Derivative of NZ3000 with integration
nisRK into chromosome; ∆lacF
[19]
 L. bulgaricus ATCC 11842 Type strain [37]
 L. plantarum ST-III Wild strain [34]
 L. casei Wild strain Our lab
 L. paracasei Wild strain Our lab
 S. thermophilus Wild strain Our lab
Plasmids
 pUC19-qk′ ApR, pUC19 containing the optimized gene qk′ TsingKe
 pNZ8048 CmR, PnisA, L. lactis expression vector [35]
 pNZ8149 lacF, PnisA, L. lactis food grade expression vector [36]
 pRF01 lacF, pNZ8149 derivate containing spUsp downstream of PnisA This study
 pRF02 lacF, pRF01 with qk downstream of spUsp This study
 pRF02H lacF, pRF02 containing qk with a His-tag This study
 pRF03 CmR, pNZ8048 derivate carrying spUsp-qk downstream of PnisA This study
 pRF03H CmR, pRF03 containing qk with a His-tag This study
 pRF04H CmR, pRF03 containing qk’ with a His-tag This study
 pRF05H CmR, pRF03 containing qkpro’ with a His-tag This study
 pRF06H CmR, pRF03 derivate containing one LysM with a His-tag from acmA fused to the 3′ end of qk This study
 pRF07H CmR, pRF06H derivate containing three LysM This study
 pRF08H CmR, pRF06H derivate containing five LysM This study
 pRF09H CmR, pRF03H containing one LysM from acmA between spUsp and qk This study
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propeptide only gene sequence qkpro′ was obtained 
by overlap PCR with the pro′ and M sequences as tem-
plates. Then, the qkpro′ was introduced into pRF03H 
by KpnI and XbaI digestion to obtain plasmid pRF05H 
(Table  2). One or three LysM repeats can be amplified 
from the chromosome of L. lactis MG1363 using prim-
ers P11 and P12 or P13. Then, these repeats were intro-
duced into plasmid pRF03 by XbaI and SacI digestion to 
obtain plasmids pRF06H and pRF07H (Table 2), respec-
tively. Using the chromosome of L. lactis MG1363, prim-
ers P11 and P14 were used to amplify three LysM repeats 
containing 15 overlapping nucleotides with the 5′ end of 
the second LysM repeat in acmA gene. Primers P13 and 
P15 were used to amplify the last two LysM repeats from 
the chromosome of L. lactis MG1363. Using primers P11 
and P13, a gene fragment containing five LysM repeats 
was obtained by overlap PCR with the above three and 
two repeats as templates. The obtained five LysM repeats 
were also introduced into plasmid pRF03 by XbaI and 
SacI digestion to obtain plasmid pRF08H (Table  2). 
The first LysM repeat was amplified from the chromo-
some of L. lactis MG1363 using primers P16 and P17 
and was then introduced into plasmid pRF03H by SphI 
and KpnI digestion to obtain plasmid pRF09H (Table 2), 
which contained one LysM repeat at the 5′ end of the qk 
gene. All plasmids were sequenced at TsingKe Biological 
Technology (Wuhan, China) to confirm the veracity and 
the correct open reading frame. In addition to L. lactis 
NZ3900 containing plasmid pRF02 or pRF02H, pRF03H 
was introduced into NZ3900, and the transformants were 
selected on GM17 plates containing chloramphenicol. All 
plasmids containing the chloramphenicol resistance gene 
constructed in this study (Table 2) were introduced into 
L. lactis NZ9000 and selected as described above.
Induction
For the secretory expression of the free Subtilisin QK-2 
or the fusion proteins, overnight cultures of the recom-
binant L. lactis NZ3900 harboring the plasmid pRF02 
or pRF02H were diluted 1:25 into fresh M17 medium 
containing 0.5 % lactose. For other recombinant strains, 
overnight cultures were diluted 1:25 into fresh M17 
medium containing 0.5  % glucose and 5  μg/ml of chlo-
ramphenicol. Strains were incubated at 30  °C without 
shaking. Nisin (Sigma) was added into the culture dur-
ing the early exponential phase of growth (OD600 ≈ 0.5) 
to induce expression. To regulate the pH of the medium, 
10 % culture volume of 5 N NaOH was added once at the 
indicated time (1, 2, or 3 h) after induction. After induc-
tion, the culture was centrifuged and both the superna-
tant culture and sonicated cell lysate were used for the 
detection and quantification of the enzyme [18].
Production of LAB GEM particles and binding conditions
Chemical pretreatment of LAB cells, including L. lactis 
MG1363, L. bulgaricus ATCC 11842, L. plantarum ST-III, 
L. casei, L. paracasei, and S. thermophiles, was performed 
with 10 % TCA. Briefly, cells of the stationary-phase cul-
tures were collected by centrifugation and washed twice 
with 0.3 volume PBS. Then, cells were resuspended in 0.2 
volume of 10 % TCA solution and boiled for 30 min. Next, 
the cells were washed three times in PBS with vigorous 
vortexing. After washing, the cells were resuspended in 
PBS at a final concentration of 2.5 × 1010 GEM particles/
ml, as determined using a Burker-Turk hemocytometer. 
GEM particles were either used immediately for binding 
experiments or stored at −80 °C until use.
For binding experiments, 2.5 × 109 GEM particles were 
added to 0.5–50  ml of cell-free supernatant containing 
fusion proteins and incubated for 30–60  min at room 
temperature in an end-over-end rotator. When needed, 
culture medium containing the fusion proteins was con-
centrated prior to binding using an Amicon Ultra-15 ml 
(Millipore). After binding, the GEM particles were col-
lected by centrifugation and washed three times with 
PBS. To test the binding efficiency, GEM particles were 
analyzed using immunofluorescence microscopy, western 
blotting or enzymatic activity analysis.
Table 3 Primers used in this study
a Underlying (single) indicates the restriction enzyme sites; Bold italics 
indicates the His6-tag sequence; Stop codons (in italics) were introduced to 
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Measure of fibrinolytic activity
Subtilisin QK-2 shows high efficiency for directly cross-
linked fibrin; therefore, the fibrinolytic activity of the above 
samples was assayed with the standard fibrin plate method 
using urokinase as the standard [1]. Holes were made on 
the fibrin plate prepared according to the previously used 
method [35]. For both the cell-free culture medium con-
taining free Subtilisin QK-2 and the GEM particles bound 
to the LysM-QK fusion proteins, 30 μl of the samples was 
dropped in the holes. Then, the plate was incubated for 
18 h at 37 °C, and the fibrinolytic activity was determined 
by measuring the diameter of the clear zone according to 
the standard curve of urokinase (Sigma).
Western blot analysis
The culture medium containing free Subtilisin QK-2 or 
the GEM particles bound to the fusion proteins were 
resuspended in SDS-PAGE loading buffer and boiled for 
10 min. The proteins were separated by 12 % SDS-PAGE 
and transferred onto a PVDF membrane (Millipore). The 
membrane was blocked overnight in 5 % solution of skim 
milk powder in Tris-buffered saline containing 0.05  % 
tween-20 (TBST) and then incubated in TBST contain-
ing 1:2000 diluted mouse His-tag monoclonal antibody 
(Proteintech, Wuhan, China) for 2 h with gentle shaking. 
After washing three times with TBST buffer, the mem-
brane was incubated with 1:6000 diluted peroxidase-
conjugated goat anti-mouse IgG (H  +  L) (Proteintech, 
Wuhan, China) for 1  h. After washing, the membrane 
was subjected to ECL hypersensitive reagents (Pierce, 
USA) and then exposed and developed.
Immunofluorescence microscopy
To further confirm that the QK and LysM fusion pro-
teins can bind to the surface of GEM particles after the 
binding assay, the pellets were resuspended in 100  μl 
PBS containing 1 % BSA and mouse His-tag monoclonal 
antibody diluted 1:50. After incubation for 1  h at room 
temperature, the GEM particles were washed three times 
with 1  ml PBS. Next, they were combined with 100  μl 
PBS containing 1 % BSA and FITC-conjugated goat anti-
mouse IgG (H + L) (Proteintech, Wuhan, China) diluted 
1:100 and incubated for 1 h. GEM particles were washed 
three times with PBS, placed on a glass slide, air-dried 
and heat-fixed. Analysis was performed on a confocal 
microscopy (Olympus Fluoview IX70).
Stability test
Simulated gastric juice (GJ) was prepared as previously 
described [36] containing 3  mg/ml pepsin (Sigma) and 
the pH was adjusted to 2.0 or 4.0. A 500  μl volume of 
10-fold concentrated cell-free culture medium contain-
ing free Subtilisin QK-2 and 500 μl loaded MG1363 GEM 
particles incubated with the same concentrated cell-free 
culture medium containing QK-3LysM fusion protein 
were combined with the same volume of simulated GJ 
or PBS (pH 7.0; positive control), respectively, and incu-
bated at room temperature for 30  min. Then, the mix-
ture was used for the analysis of fibrinolytic activity as 
described above.
Codon usage analysis
A graphical codon usage analyzer (http://www.gcua.sch-
oedl.de/) [37] was used to compare the codon usage in the 
Subtilisin QK-2 gene qk with the codon usage table of L. 
lactis MG1363 (http://www.kazusa.or.jp/codon). Codon 
usage between 10 and 20 % for a particular codon is con-
sidered as “rather low” and below 10 % as “very low” [20].
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